(Alliance News) - Imaging Biometrics Ltd on Friday said it has entered a research and commercial partnership with personalised cancer medicine firm Vivan Therapeutics to explore potential anti-cancer ...
Goldman Sachs raises Bunzl to 'neutral' (sell) - price target 2,510 (2,375) pence Citigroup raises Schroders to 'buy' (neutral) - price target 435 (420) pence RBC raises Diploma to 'outperform' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback